Cross-Sector entity
Howard Lutnick is the most frequent co-covered peer, appearing in 5 of the 18 tracked stories. Across a 180-day span, the pace is roughly 0.7 stories per week. The busiest single day carried 3. earnings accounts for 4 of the 18 tracked stories, while 9 other categories carry the remainder.
18 verified stories tracked
Last mentioned: Aug 17, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 17 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Howard Lutnick is the most frequent co-covered peer, appearing in 5 of the 18 tracked stories. Across a 180-day span, the pace is roughly 0.7 stories per week. The busiest single day carried 3. earnings accounts for 4 of the 18 tracked stories, while 9 other categories carry the remainder. We currently track 18 Cross-Sector stories that mention Cantor Fitzgerald, published between February 19, 2026 and August 17, 2026. 39% of these stories carry negative sentiment. The tracked stories average 2.7 original sources each.
Computed from the 18 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Cantor Fitzgerald. Shared-story counts are live from our verified record — not editorial picks.
Wall Street Zen upgrades BKKT and DEI
Wall Street Zen upgraded Bakkt and Douglas Emmett from sell to hold in research notes issued Saturday morning.
Earnings release
Replimune Group reported ($0.72) EPS, missing the ($0.69) Zacks consensus by $0.03. Stock opened at $14.97, down $0.22.
Benchmark cuts BKKT target
Benchmark reduced its Bakkt price target from $19.00 to $12.00 while maintaining a buy rating.
Insider sales
CEO Sushil Patel sold 39,341 shares at $12.97 and insider Konstantinos Xynos sold 11,447 shares at $12.97, both to cover tax withholding obligations.
Bakkt reports quarterly results
Bakkt announced EPS of $1.94 and revenue of $170.15 million, missing revenue consensus of $373.27 million.
Wedbush upgrade
Wedbush upgraded Replimune Group from neutral to outperform and set a $12.00 price target.
Cantor Fitzgerald raises DEI target
Cantor Fitzgerald raised its Douglas Emmett target price from $12.00 to $13.00 with a neutral rating.
Leerink upgrade
Leerink Partners upgraded Replimune Group from market perform to outperform and raised its price target from $11.00 to $17.00.
Douglas Emmett reports earnings
Douglas Emmett reported quarterly EPS of negative $0.02.
Weiss Ratings upgrades DEI
Weiss Ratings upgraded Douglas Emmett from a sell (d) rating to a sell (d+) rating.
Scotiabank raises DEI target
Scotiabank raised its Douglas Emmett target price from $12.00 to $13.00 with a sector perform rating.
Q2 2026 Earnings Release
Home BancShares reports Q2 EPS of $0.64, beating consensus of $0.62; stock rises 1%.
Cantor–Securitize Partnership Announced
Cantor Fitzgerald and Securitize reveal a collaboration to bring IPOs on-chain, integrating tokenization into primary issuance for the first time.
DTCC Unveils Tokenization Plans
DTCC announces plans to tokenize stocks in partnership with JPMorgan, Goldman Sachs, BlackRock, and Vanguard, signaling accelerating institutional interest in on-chain equities.
Weiss Ratings upgrades BKKT
Weiss Ratings upgraded Bakkt from a sell (e+) rating to a sell (d-) rating.
BMO upgrade
BMO Capital Markets raised Replimune Group from underperform to outperform with a $16.00 price target.
Bakkt director buys 100,000 shares
Director Michael Alfred purchased 100,000 BKKT shares at $7.83 each, totaling $783,000.
Dividend Payment
Quarterly dividend of $0.21 per share paid to shareholders of record on May 13.
Wells Fargo lifts DEI target
Wells Fargo raised its Douglas Emmett price target from $13.00 to $14.00 with an overweight rating.
Weiss Ratings Downgrades
Weiss Ratings downgrades Home BancShares from Buy (B-) to Hold (C+).
Wall Street Zen's sell-to-hold upgrade for Bakkt comes as the stock trades at $7.66 with a $341.53 million market cap. The move follows a 54% revenue miss and a director's $783,000 insider buy, leaving analysts divided on whether this is a bottom or a value trap.
Crypto platform Bakkt's sell-to-hold upgrade masks a brutal year: shares at $7.66 are down 85% from $49.79. A director's insider buy and an extreme beta of 5.91 frame the risk-reward for Web3 investors watching custody and exchange infrastructure.
Source: tickerreport.com · themarketsdaily.com
Replimune missed consensus EPS by $0.03 but held near its 52-week high at $14.97. Insider sales totaling over $650,000 were tax-related, while analyst targets now range up to $17, creating a gap between the $11.86 average target and the stock price.
Replimune reported ($0.72) EPS, missing by $0.03, but for biotech investors the quarter is a side note to pipeline catalysts and analyst upgrades. Insider sales were tax-related, and recent price targets of $16 to $17 suggest confidence in the oncolytic immunotherapy platform.
Source: tickerreport.com · themarketsdaily.com
SoundHound AI (SOUN) and NuScale Power (SMR) report earnings August 5, both down sharply in 2026 but backed by bullish analyst targets. SoundHound’s average target of $12.75 implies over 100% upside, while NuScale eyes a $10 trillion nuclear market. Key metrics on cross-selling and project execution could ignite rallies.
As AI's energy demands soar, NuScale Power's Q2 earnings could prove pivotal for the nuclear small modular reactor sector. The sole U.S.-cleared SMR company faces execution risks but holds a massive project pipeline, including a 6 GW system. Positive updates may accelerate the clean energy transition.
SoundHound AI's second-quarter earnings on August 5 will gauge whether its strategy of cross-selling voice AI products—bolstered by the Amelia acquisition—is delivering accelerated growth. As AI voice interfaces expand across industries, this report could validate the company's enterprise pivot amid a 40% stock decline.
Source: The Motley Fool · Ryan Vanzo (us)
By tokenizing IPOs, Cantor and Securitize could slash the cost and complexity of going public for startups. The move promises faster settlement, broader investor access, and a potential paradigm shift for how venture-backed companies tap public capital.
Cantor Fitzgerald and Securitize are set to tokenize the entire IPO process on blockchain, a landmark advance for security tokens. The partnership, alongside DTCC’s tokenization push, underscores a rapid shift toward on-chain capital markets and could unlock trillions in asset value.
Source: coindesk.com
Home BancShares delivered a $0.64 per share Q2 profit, edging past consensus by $0.02. The bank's 32.48% net margin and conservative balance sheet keep it as a defensive play in a shaky regional banking sector. With a P/E of 12 and a 2.9% dividend yield, HOMB offers income and value in a stock that barely moved on the beat.
Source: MarketBeat · Zacks
Cantor Fitzgerald raised $210M for a partner in the Kazakhstan tungsten mine, while Trump sons’ Dominari grabbed a 20% equity stake—all while their fathers negotiated $1.6B in federal backing. The NYT uncovers an $8.9B web of conflicts.
As the U.S. seeks to break China’s 80% tungsten monopoly, a $1.6B Kazakhstan mine deal embroiled in Trump and Lutnick family profiteering threatens to stall critical mineral supply chain efforts, alongside $8.9B in similarly tainted projects.
Key tungsten deposit for missile warheads becomes entangled in family profiteering as Trump sons’ firm takes a 20% stake in a $1.6 billion federally backed project. The scandal casts a shadow over U.S. defense supply chain diversification.
Source: Sph Media Limited (sg) · presstv.ir
Oracle is emerging as a primary contender for the $1 trillion market cap milestone, propelled by the rapid scaling of Oracle Cloud Infrastructure (OCI) and high-performance AI workloads. Strategic partnerships with NVIDIA and a shift toward multi-cloud availability for its flagship database are driving a significant valuation re-rating.
Source: fool.com · finance.yahoo.com
Commerce Secretary Howard Lutnick is facing intense questioning from House Democrats regarding his historical business ties to the Epstein family and potential conflicts of interest in the rare earth minerals sector. The inquiry focuses on 'tariff refund wagers' and how his current role overseeing trade policy might intersect with his private financial history.
Democratic lawmakers are intensifying their oversight of Commerce Secretary Howard Lutnick, focusing on potential conflicts of interest involving rare earth minerals and specific tariff refund requests. The inquiry centers on Lutnick's prior business ties and allegations of favorable treatment for entities linked to the Epstein family.
Rivian Automotive shares fell over 7% on Tuesday, retreating from a recent post-earnings rally as investors weighed the execution risks of the upcoming R2 SUV launch. Despite several Wall Street firms raising price targets following a fourth-quarter gross profit beat, the market remains cautious about the company's path to sustained profitability in 2026.
Rivian Automotive shares fell over 7% despite several Wall Street firms raising price targets following a strong Q4 performance. Investors are increasingly focused on the critical R2 SUV launch, which remains the primary catalyst for the company's goal of achieving full-year gross profitability by 2026.
Source: Yahoo Finance · Howard Smith (us)
